License the latest technology from Imperial College London
Technology available for licensing
Imperial College London is among the world’s leading research universities, and one of the few focused exclusively on Science, Technology, Engineering, Medicine and Business. Technology developed by Imperial’s world-leading researchers is protected and packaged by our expert commercialisation specialists.
Available technologies span all areas of research undertaken at Imperial. If your business is considering licensing technology, you can view available technologies and enquire directly through this site.
Available technologies
Browse technologies and innovations derived from research undertaken by academics at Imperial College London
Non-Pneumatic Particle Jamming for Low-Cost, Compact Haptic Feedback Devices
Alternative methods for particle jamming to create simulated hardness in haptic feedback devices at lower cost compared to pneumatic systems
In situ RTQuIC seeding amplification assay for neurodegeneration
A seeding amplification assay with spatial resolution that visualises protein misfolding and aggregation in intact biological samples to study the mechanisms of neurodegeneration and cross-seeding between diseases.
Assay to detect active viral infection
Mass spectrometry assay measuring 3'-deoxy-3',4'-didehydro-cytidine (ddhC) to quantitatively detect active viral infections
Novel integrase-based system for enabling nitrogen fixation in non-fixing yet agriculturally relevant bacterial chassis
Seamless integration of large nitrogen fixation clusters into virtually any bacterial strain – unlocking exciting new frontiers in biofertilisers
EffiTrap: comprehensive and real-time defect analysis for semiconductors
Advanced real-time defect characterization for semiconductors, including imaging sensors, optical sensors, and photovoltaics
High Quality Quantification of Cardiac Anatomy and Function through 3D deep learning
Accurate quantification of cardiac anatomy and function using sparse 2D echo images achieved with an algorithm that reconstructs 3D model from 2D images.
LhARA: A radiobiological cancer therapy
LhARA is a Laser hybrid Accelerator for Radiobiological Applications in which laser interactions drive the creation of a large flux of protons or light ions.
Polymers with Anti-Microbial Properties
A new way to manufacture antimicrobial polymers in which an anti-microbial agent is blended into a polymer matrix through melt blending.
Microbial Peptides for the Therapeutic Modulation of the Human Gut-Brain Axis
Utilising peptides derived from healthy human gut microbiome, this technology offers potential therapeutic applications in treating disorders related to mood, behaviour, and gastrointestinal function by modulating the gut-brain axis.
Artificial Intelligence (AI) tool for measuring eczema severity in diverse skin tones
An AI tool for remote assessment of eczema severity for diverse skin types.
Featured inventor
Dr Stefano Angioletti-Uberti
Academic title - Senior Lecturer
Faculty - Faculty of Engineering, Department of Materials
Upcoming Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Latest News
Accelerated development of a potential treatment for cystic fibrosis
The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim. Find out more
Natural Killer – licensing a cell therapy
Imperial has licensed iNKT cell technology based on research by Prof. Tassos Karadimitris to SUDA Pharmaceuticals. Find out more
Imperial partner Apollo receives £100m to boost medical research at leading unis
Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model. Find out more
Sign up for updates
Sign up for monthly technology alerts via email, and find other ways to connect with us.